Technology

Scottish biotech ILC Therapeutics signs R&D partnership with Dechra Pharmaceuticals

SCOTTISH biotech ILC Therapeutics has signed a R&D partnership with Dechra Pharmaceuticals PLC which will see international veterinary group Dechra and ILC Therapeutics develop ILC’s Caniferon product to treat atopic dermatitis in dogs.  Atopic dermatitis

Blockchain report highlights technology worth over £4bn to Scottish economy by 2030
Edinburgh tech entrepreneur warns of impact of fake review ‘epidemic’ at global US conference
New £1 billion strategy to boost UK’s global strengths in semiconductors and invest in infrastructure, research and security
One third of UK Companies lack basic tech skill
New English partnership extends reach of The Data Lab
Cloud no longer the new kid on the block: But SMEs risk falling behind
42% of IT leaders told to keep data breaches confidential
Scots health tech could hold key to cervical cancer treatment
Forrit CEO says updated CMS makes it “easier than ever to securely build and edit websites”